Enliven Therapeutics
ELVN
#5396
Rank
ยฃ0.86 B
Marketcap
ยฃ17.62
Share price
-1.78%
Change (1 day)
50.69%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ13.59 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are ยฃ13.59 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ20.37 M-84.6%
2022-12-31ยฃ0.13 B14.37%
2021-12-31ยฃ0.11 B4.26%
2020-12-31ยฃ0.11 B